Top Suppliers:I want be here

1869912-40-2

1869912-40-2 structure
1869912-40-2 structure
  • Name: AZD-5153 6-hydroxy-2-naphthoic acid
  • Chemical Name: AZD5153
  • CAS Number: 1869912-40-2
  • Molecular Formula: C36H41N7O6
  • Molecular Weight: 667.75
  • Catalog: Signaling Pathways Epigenetics Epigenetic Reader Domain
  • Create Date: 2018-01-26 03:04:20
  • Modify Date: 2024-01-02 11:39:49
  • AZD5153 6-Hydroxy-2-naphthoic acid is the 6-Hydroxy-2-naphthoic acid of AZD5153. AZD5153 is a potent, selective, and orally available BET/BRD4 bromodomain inhibitor; disrupts BRD4 with an IC50 of 1.7 nM.

Name AZD5153
Synonyms 6-Hydroxy-2-naphthoic acid
Description AZD5153 6-Hydroxy-2-naphthoic acid is the 6-Hydroxy-2-naphthoic acid of AZD5153. AZD5153 is a potent, selective, and orally available BET/BRD4 bromodomain inhibitor; disrupts BRD4 with an IC50 of 1.7 nM.
Related Catalog
Target

IC50: 1.7 nM (BRD4)[1]

In Vitro AZD5153 demonstrates a remarkable enhancement in potency for the displacement of full-length BRD4 relative to BD1, with IC50 values of 5.0 nM and 1.6 μM, respectively. AZD5153 potently disrupts BRD4 foci in U2OS cells with an IC50 value of 1.7 nM. AZD5153 efficiently down-regulates MYC protein levels across the cell line panel irrespective of their sensitivity to AZD5153[1].
In Vivo Administration of AZD5153 leads to tumor stasis or regression in multiple xenograft models of acute myeloid leukemia, multiple myeloma, and diffuse large B-cell lymphoma. AZD5153 treatment markedly impacts transcriptional programs of MYC, E2F, and mTOR[1].
Animal Admin Mice: Mice are treated with either vehicle (0.5% hydroxymethylcellulose, 0.1% Tween80) or AZD5153 by oral gavage mini-pump infusion. For continuous administration of AZD5153, compound is solubilized in 20% v/v DMSO/60% v/v HP-B-CD in water, loaded into a mini pump and implanted subcutaneously in mice. Tumor fragments collected are snap frozen or fixed in 10% buffered formalin. Blood samples are collected from the same mice and stabilized in EDTA. Plasma concentrations are determined by liquid chromatography/tandem mass spectrometry method[1].
References

[1]. Rhyasen GW, et al. AZD5153: A Novel Bivalent BET Bromodomain Inhibitor Highly Active against Hematologic Malignancies. Mol Cancer Ther. 2016 Nov;15(11):2563-2574.

Molecular Formula C36H41N7O6
Molecular Weight 667.75
Storage condition -20℃
Water Solubility DMSO: ≥ 34 mg/mL